Angiogenic therapy for bronchopulmonary dysplasia: rationale and promise

Circulation. 2005 Oct 18;112(16):2383-5. doi: 10.1161/CIRCULATIONAHA.105.574061.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiogenesis Inducing Agents / therapeutic use*
  • Bronchopulmonary Dysplasia / embryology
  • Bronchopulmonary Dysplasia / etiology
  • Bronchopulmonary Dysplasia / therapy*
  • Genetic Therapy
  • Humans
  • Infant, Newborn
  • Pulmonary Alveoli / blood supply*
  • Vascular Endothelial Growth Factor A / genetics*
  • Vascular Endothelial Growth Factor A / therapeutic use

Substances

  • Angiogenesis Inducing Agents
  • Vascular Endothelial Growth Factor A